Novo Nordisk Clinical Innovation Centre A/S
Public limited companyCVR 46290003GentofteActive
Novo Nordisk Clinical Innovation Centre A/S is a public limited company, based in Gentofte, active in research and experimental development on natural sciences and engineering, founded in 2026. The company is new and has been registered for less than a year. With 32 employees, the company is about 6 times larger than the industry median. 6 people are registered in the company's management and ownership.
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Poul-Martin Haahr (ceo, 26/02/2026), Filip Krag Knop (board member, 26/02/2026) and Joan Toftegaard Boesen (board member, 26/02/2026) (+3).
- Stepped down: Desirée Thielke Thyssen (board member, 11/03/2026).
- New owners registered: Novo Nordisk Region Europe A/S (26/02/2026).
Registrations, last 24 months
- 01/05/2026: Share capital changed from 400,000 DKK to 400,001 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Compare with the industry
Research and experimental development on natural sciences and engineering- Novo Nordisk Clinical Innovation Centre A/S–
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Novo Nordisk Clinical Innovation Centre A/S–
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Novo Nordisk Clinical Innovation Centre A/S–
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Novo Nordisk Clinical Innovation Centre A/S32
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Nordisk Region Europe A/S100%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Poul-Martin Haahr | CEO | 26/02/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Filip Krag Knop | Board member | 26/02/2026 |
| Joan Toftegaard Boesen | Board member | 26/02/2026 |
| Marianne Ølholm | Board member | 26/02/2026 |
| Desirée Thielke Thyssen | Chair of the board | 12/03/2026 |
- Founders
- Novo Nordisk Region Europe A/S
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Desirée Thielke Thyssen | Board member | 26/02/2026 | 11/03/2026 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør.
Address and production units
1 active production unitsNiels Steensens Vej 2B
2820 Gentofte
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Novo Nordisk Clinical Innovation Centre A/S | Niels Steensens Vej 2B, 2820 Gentofte | 33 | 1032170222 |
Purpose
Selskabets formål er at gennemføre kliniske afprøvninger af lægemiddelstoffer og andre kliniske forskningsaktiviteter. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
The purpose is quoted from the register in Danish.
Changes year by year
10 registered events202610 changescapital 1 · management 7 · founded 1 · ownership 1
- CapitalShare capital changed from 400,000 DKK to 400,001 DKK
- ManagementDesirée Thielke Thyssen appointed chair of the board
- ManagementDesirée Thielke Thyssen stepped down as board member
- FoundedRegistered as Novo Nordisk Clinical Innovation Centre A/S
- ManagementDesirée Thielke Thyssen appointed board member
- ManagementPoul-Martin Haahr appointed ceo
- ManagementFilip Krag Knop appointed board member
- ManagementJoan Toftegaard Boesen appointed board member
- ManagementMarianne Ølholm appointed board member
- OwnershipNOVO NORDISK REGION EUROPE A/S registered as owner (100%)
Related companies
Same industry in Gentofte
- Pharmaceutical Research Associates Denmark ApS50 employees
- Bioporto Diagnostics A/S28 employees
- NIVI Development A/S9 employees
- Bioporto A/S8 employees
- Protein Frontiers ApS4 employees
- Aetas Labs ApS4 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.